The Sermo Medical Advisory Board (MAB) is comprised of members from around the globe in a variety of specialties who have come together to amplify physicians’ voices in an ever-changing healthcare ecosphere.
With the help of the Sermo Medical Advisory Board, Sermo offers cutting edge insights to the global healthcare community, aiming to move the industry forward and drive positive patient outcomes around the world.
Our members
Sermo MAB Highlights
Members offer expertise, guidance and counsel that inform the Sermo community, product roadmap and marketing initiatives as well as the industry at large.
Showing up in the wild
At Fierce Pharma Week / Digital Pharma East in Philadelphia, members shared their insight during a Sermo panel discussion about ways in which pharma can most effectively engage with physicians throughout the product lifecycle.
“How can pharma most successfully engage KOLs?” Neurologist and Clinical Research Director Dr. Shivang Joshi emphasized the importance of authenticity, advocacy and disease state education in this “Short Takes” interview with the Digital Health Coalition (DHC).
Speaking out in the press
Sermo MAB members weigh in on important topics from practice-changing therapies to policy in top tier national, international and healthcare media.
“What was initially sold as a $1,000 MRI could now have you out of pocket for tens of thousands of dollars and lead to nothing except physical, mental, and financial pain.”
– Dr. Ashish Rana, MD